← Back to Search

Blood Collection Device Validation for Patients on Blood Thinners

Verified Trial
N/A
Waitlist Available
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
>=18 yrs.
We are looking for participants currently on anticoagulants such as Pradaxa®, Xarelto®, Eliquis®, Coumadin®, Normiflo ®, Fragmin®, or Lovenox®.
Timeline
Screening 1 day
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial is for a medical device manufacturer to qualify their line of blood collection tubes with the FDA. Participants who are currently on anticoagulants will be compensated for their time and resources.

Who is the study for?
This trial is for adults over 18 who are taking blood thinners like Pradaxa®, Xarelto®, Eliquis®, Coumadin®, Normiflo ®, Fragmin®, or Lovenox®. Participants need to be able to travel to a lab for a blood draw.Check my eligibility
What is being tested?
The study aims to validate new blood collection tubes by drawing about 3.5 tablespoons of blood from participants on anticoagulants, helping address the shortage of these tubes in healthcare.See study design
What are the potential side effects?
Since this trial involves only a standard blood draw, side effects may include temporary discomfort at the puncture site, light-headedness, bruising, or bleeding.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am currently taking blood thinners like Pradaxa, Xarelto, or Coumadin.
Select...
I am taking Warfarin or Low Molecular Weight Heparin.
Select...
I am 18 years old or older.
Select...
I am currently taking blood thinners like Pradaxa, Xarelto, or similar.
Select...
I am taking Warfarin or Low Molecular Weight Heparin.

Timeline

Screening ~ 1 day
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 1 day for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Placebo Group
Group I: ParticipantsPlacebo Group1 Intervention
Anyone on Warfarin or Low Molecular Weight Heparin

Find a Location

Who is running the clinical trial?

Media Library

Blood Draw Clinical Trial Eligibility Overview. Trial Name: BDICON35 — N/A
Taking Blood Thinners Research Study Groups: Participants
Taking Blood Thinners Clinical Trial 2023: Blood Draw Highlights & Side Effects. Trial Name: BDICON35 — N/A
Blood Draw 2023 Treatment Timeline for Medical Study. Trial Name: BDICON35 — N/A
Taking Blood Thinners Patient Testimony for trial: Trial Name: BDICON35 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
65+
What site did they apply to?
1. Machaon Diagnostics
Machaon Diagnostics
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
1

Why did patients apply to this trial?

The ad…the location…and previous visit there for “Eliquis” blood thinners study….
PatientReceived 1 prior treatment
I want to help improve healthcare for those with possible blood clots or stroke potential .
PatientReceived 2+ prior treatments

How responsive is this trial?

Typically responds via
Email
Recent research and studies
clinicaltrials.govStudy
Device validation study using blood from patients on Warfarin or Low Molecular Weight Heparin.
2022. "Device validation study using blood from patients on Warfarin or Low Molecular Weight Heparin.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/BDICON35.
All > Afib > Ic
~124 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top